e-learning
resources
Madrid 2019
Monday, 30.09.2019
Clinical investigations of non-TB mycobacterial infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adherence to NTM treatment guidelines in three reference centers in Belgium
N. Cardinaels (Leuven, Belgium), Y. Vande Weygaerde (Ghent, Belgium), P. Bomans (Antwerpen, Belgium), T. Chin (Ghent, Belgium), E. Van Braeckel (Ghent, Belgium), N. Lorent (Leuven, Belgium)
Source:
International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Session:
Clinical investigations of non-TB mycobacterial infection
Session type:
Thematic Poster
Number:
2934
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Cardinaels (Leuven, Belgium), Y. Vande Weygaerde (Ghent, Belgium), P. Bomans (Antwerpen, Belgium), T. Chin (Ghent, Belgium), E. Van Braeckel (Ghent, Belgium), N. Lorent (Leuven, Belgium). Adherence to NTM treatment guidelines in three reference centers in Belgium. 2934
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Adherence to the recommendation of prescribing 4 drugs in the intensive phase of the standard treatment of tuberculosis in Spain
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Are TB services in England adhering to new NICE guidelines on screening for latent TB?
Source: International Congress 2017 – Migrants and screening
Year: 2017
Centralization of M/XDR-TB care in clinical reference centres in Portugal. Experience of a regional reference centre
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Source: Eur Respir J 2011; 38: 516-528
Year: 2011
Clinical effectiveness of recommended antibiotics in COVID19 pneumonias; assessing national referral centre guidance
Source: Virtual Congress 2021 – COVID - 19 treatments
Year: 2021
The new ATS and ERS TB treatment guidelines
Source: International Congress 2016 – ERS and tuberculosis
Year: 2016
Community acquired pneumonia in Greece: clinical, laboratory data – adherence to the international guidelines
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis
Source: Eur Respir J 2016; 48: 963-971
Year: 2016
Developing standards for TB and MDR-TB management in the European Union setting
Source: Annual Congress 2010 - Multidrug-resistant tuberculosis and novel influenza: back to the future - "Lessons learnt from two respiratory emergencies"
Year: 2010
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
Community acquired pneumonia in Greece: Clinical, microbiological data and adherence to the IDSA guidelines
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010
Recommended standards for modern tuberculosis laboratory services in Europe
Source: Eur Respir J 2006; 28: 903-909
Year: 2006
Active case-finding of tuberculosis in Europe
Source: Annual Congress 2007 - Clinical epidemiology of tuberculosis
Year: 2007
Tuberculosis: cost of illness in Germany
Source: Eur Respir J 2012; 40: 143-151
Year: 2012
The impact of national recommendations on antibiotic treatment of community acquired pneumonia. Do pediatricians follow the national guidelines?
Source: International Congress 2017 – Pulmonary infection and inflammation
Year: 2017
Local antibiotic guidelines for management of adult community acquired pneumonia in UK hospitals
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
MDR-TB guidelines: what is new on clinical management
Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management
Year: 2020
The implementation of IDSA/ATS and the Greek national guidelines for CAP by chest physicians in Greece
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Community acquired pneumonia guidelines: not only treatment indications
Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis
Year: 2004
Adherence to GOLD guidelines practices in the management of COPD in Tunisia
Source: International Congress 2018 – COPD around the world
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept